Prodotti competitors / Area Kite, Area Onco-Ema 18 settembre 2024 Poseida Therapeutics has received the Regenerative Medicine Advanced Therapy (RMAT) designation from FDA for its investigational stem cell memory (TSCM) T cell-based allogeneic CAR-T (P-BCMA-ALLO1)
